legislation: 104-s-1496

Congressional bills and resolutions from Congress.gov, filtered to policy areas relevant to environmental, health, agriculture, and wildlife regulation.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

bill_id congress bill_type bill_number title policy_area introduced_date latest_action_date latest_action_text origin_chamber sponsor_name sponsor_state sponsor_party sponsor_bioguide_id cosponsor_count summary_text update_date url
104-s-1496 104 s 1496 A bill to grant certain patent rights for certain non-steroidal anti-inflammatory drugs for a two year period. Commerce 1995-12-21 1995-12-21 Read twice and referred to the Committee on Judiciary. Senate Sen. Simon, Paul [D-IL] IL D S000423 3 Entitles the owner of the right to market a non-steroidal anti-inflammatory drug that contains a previously patented active agent, that has been reviewed by the Food and Drug Administration (FDA) for more than 120 months as a new drug application, and that was approved as safe and effective by the FDA on October 29, 1992, to exclude others from making, using, offering for sale, selling, or importing such active agent for two years beginning October 29, 1997. Applies the prohibition on infringement of patents to such entitlement. Prohibits submission of an application under the Federal Food, Drug, and Cosmetic Act for introduction into interstate commerce of a drug claimed in a patent, or the use of which is claimed in a patent, before the expiration of such entitlement. 2025-07-21T19:32:26Z  

Links from other tables